MedPath

Ameliorative effect of LOTORIGA on memory in elderly with hyperlipidemia

Phase 4
Recruiting
Conditions
hyperlipidemia
Registration Number
JPRN-UMIN000032734
Lead Sponsor
Shimane University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

patients with hemorrhage, prescription of EPA drug, anticoagulants, NSAIDs excluding Aspirin, anti-acetylcholine esterase, supplements such as DHA or Beta-carotene

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath